Domov › Mnohonásobný myelóm › New York › Queens
Klinické štúdie Mnohonásobný myelóm v meste Queens, NY
20 štúdií pre Mnohonásobný myelóm hľadá účastníkov v zariadeniach v meste Queens a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Prebieha náborFáza 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Prebieha náborFáza 3
- NYU Winthrop, Mineola · 11 míľ odtiaľ
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Prebieha náborFáza 3
- Northwell Health Cancer Institute, Lake Success · 9 míľ odtiaľ
- NYU Langone Hospital Long Island, Mineola · 11 míľ odtiaľ
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Prebieha náborFáza 3
- MSK Nassau, Uniondale · 13 míľ odtiaľ
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Prebieha náborFáza 2
- Queens Cancer Center, Rego Park · 3 míľ odtiaľ
- Cohen Children's Medical Center, New Hyde Park · 9 míľ odtiaľ
- Northwell Health Monter Cancer Center, Lake Success · 9 míľ odtiaľ
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 míľ odtiaľ
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Prebieha náborFáza 3
- Long Island Jewish Medical Center, New Hyde Park · 9 míľ odtiaľ
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 míľ odtiaľ
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Prebieha náborFáza 3
- MSK Nassau, Uniondale · 13 míľ odtiaľ
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Prebieha náborFáza 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Prebieha náborFáza 3
- Research Site, New Hyde Park · 9 míľ odtiaľ
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Prebieha náborObservačná štúdia
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 míľ odtiaľ
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Prebieha náborFáza 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Prebieha náborFáza 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 míľ odtiaľ
A Dietary Study for People With Multiple Myeloma
Prebieha nábor
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Prebieha náborFáza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 míľ odtiaľ
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Memorial Sloan Kettering Rockville, Rockville Centre · 10 míľ odtiaľ
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Prebieha nábor
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 míľ odtiaľ
Štúdie Mnohonásobný myelóm v iných mestách
- New York City, NY60 štúdií
- Boston, MA42 štúdií
- Atlanta, GA41 štúdií
- Houston, TX38 štúdií
- Durham, NC37 štúdií
- Nashville, TN32 štúdií
- Denver, CO27 štúdií
- Rochester, MN24 štúdií
- St. Louis, MO24 štúdií
- Columbus, OH24 štúdií
- Baldwin Park, CA23 štúdií
- Chicago, IL22 štúdií
Iné štúdie v Queens
- Rakovina prsníka63 štúdií
- Nemalobunkový karcinóm pľúc49 štúdií
- Kolorektálny karcinóm31 štúdií
- Metastatická rakovina28 štúdií
- Rakovina vaječníkov28 štúdií
- Rakovina prostaty27 štúdií
- Rakovina (všetky typy)26 štúdií
- Rakovina endometria25 štúdií
- Rakovina pľúc22 štúdií
- Akútna myeloidná leukémia21 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku20 štúdií
- Rakovina pankreasu20 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.